Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizosaccharomyces | 28 | 2023 | 104 | 7.990 |
Why?
|
| DNA Replication | 21 | 2022 | 247 | 6.370 |
Why?
|
| Replication Origin | 13 | 2022 | 36 | 4.900 |
Why?
|
| Schizosaccharomyces pombe Proteins | 20 | 2023 | 73 | 3.940 |
Why?
|
| DNA Damage | 12 | 2017 | 297 | 2.610 |
Why?
|
| DNA Replication Timing | 8 | 2022 | 17 | 2.580 |
Why?
|
| S Phase | 12 | 2021 | 79 | 2.380 |
Why?
|
| Gene Expression Regulation, Fungal | 10 | 2017 | 127 | 1.930 |
Why?
|
| Cell Cycle Proteins | 11 | 2024 | 402 | 1.870 |
Why?
|
| Cell Size | 3 | 2021 | 41 | 1.820 |
Why?
|
| Mitosis | 4 | 2024 | 222 | 1.710 |
Why?
|
| Minichromosome Maintenance Proteins | 3 | 2021 | 5 | 1.630 |
Why?
|
| Genome, Fungal | 6 | 2021 | 42 | 1.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2024 | 182 | 1.070 |
Why?
|
| Cell Division | 3 | 2019 | 450 | 0.980 |
Why?
|
| DNA, Fungal | 5 | 2017 | 58 | 0.950 |
Why?
|
| Thymidine | 3 | 2015 | 25 | 0.940 |
Why?
|
| Chromatin | 5 | 2022 | 641 | 0.890 |
Why?
|
| S Phase Cell Cycle Checkpoints | 2 | 2017 | 3 | 0.870 |
Why?
|
| Eukaryotic Cells | 2 | 2023 | 57 | 0.860 |
Why?
|
| Cell Cycle Checkpoints | 3 | 2017 | 47 | 0.800 |
Why?
|
| DNA-Binding Proteins | 7 | 2011 | 1225 | 0.800 |
Why?
|
| Models, Biological | 7 | 2021 | 1192 | 0.750 |
Why?
|
| Replicon | 1 | 2022 | 1 | 0.730 |
Why?
|
| Cyclin B | 1 | 2021 | 17 | 0.680 |
Why?
|
| Signal Transduction | 6 | 2012 | 3153 | 0.660 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2010 | 88 | 0.640 |
Why?
|
| Cell Enlargement | 1 | 2019 | 9 | 0.590 |
Why?
|
| G2 Phase | 4 | 2017 | 23 | 0.590 |
Why?
|
| Genome, Human | 1 | 2021 | 237 | 0.590 |
Why?
|
| Evolution, Molecular | 5 | 2013 | 350 | 0.580 |
Why?
|
| DNA | 4 | 2024 | 858 | 0.570 |
Why?
|
| DNA Helicases | 3 | 2022 | 198 | 0.560 |
Why?
|
| Chromosomes | 2 | 2024 | 139 | 0.550 |
Why?
|
| Molecular Biology | 2 | 2017 | 65 | 0.550 |
Why?
|
| Genetics, Microbial | 1 | 2017 | 11 | 0.520 |
Why?
|
| Eukaryota | 2 | 2016 | 31 | 0.510 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 42 | 0.510 |
Why?
|
| Models, Genetic | 3 | 2013 | 266 | 0.490 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 197 | 0.490 |
Why?
|
| Estradiol | 1 | 2017 | 259 | 0.470 |
Why?
|
| Stochastic Processes | 3 | 2012 | 28 | 0.460 |
Why?
|
| Kinetics | 6 | 2019 | 760 | 0.450 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 687 | 0.420 |
Why?
|
| Staining and Labeling | 1 | 2015 | 127 | 0.410 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2017 | 128 | 0.410 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 414 | 0.400 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2021 | 570 | 0.360 |
Why?
|
| Checkpoint Kinase 2 | 5 | 2016 | 28 | 0.360 |
Why?
|
| CDC2 Protein Kinase | 2 | 2012 | 38 | 0.340 |
Why?
|
| Cell Cycle | 4 | 2017 | 398 | 0.330 |
Why?
|
| Genome | 1 | 2013 | 285 | 0.330 |
Why?
|
| DNA Repair | 2 | 2009 | 262 | 0.320 |
Why?
|
| Methyl Methanesulfonate | 3 | 2017 | 5 | 0.310 |
Why?
|
| Protein Binding | 4 | 2021 | 1640 | 0.310 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 32 | 0.280 |
Why?
|
| Epistasis, Genetic | 1 | 2008 | 44 | 0.280 |
Why?
|
| Endonucleases | 1 | 2008 | 84 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 210 | 0.270 |
Why?
|
| Homeostasis | 2 | 2021 | 379 | 0.260 |
Why?
|
| Nucleosomes | 3 | 2016 | 190 | 0.260 |
Why?
|
| Species Specificity | 3 | 2013 | 339 | 0.260 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1630 | 0.240 |
Why?
|
| Chromosome Segregation | 2 | 2024 | 43 | 0.240 |
Why?
|
| Tyrosine | 1 | 2006 | 93 | 0.240 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 907 | 0.230 |
Why?
|
| Transcription Factors | 2 | 2011 | 1556 | 0.210 |
Why?
|
| Transcription Initiation Site | 2 | 2021 | 47 | 0.200 |
Why?
|
| Animals | 7 | 2024 | 21345 | 0.200 |
Why?
|
| Chromosomal Instability | 2 | 2017 | 20 | 0.200 |
Why?
|
| Exodeoxyribonucleases | 3 | 2010 | 29 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2023 | 50 | 0.200 |
Why?
|
| Flow Cytometry | 4 | 2009 | 663 | 0.200 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2015 | 35 | 0.180 |
Why?
|
| Bromodeoxyuridine | 2 | 2015 | 44 | 0.180 |
Why?
|
| Origin Recognition Complex | 1 | 2021 | 3 | 0.170 |
Why?
|
| Indoleacetic Acids | 1 | 2021 | 31 | 0.170 |
Why?
|
| Humans | 11 | 2024 | 65140 | 0.170 |
Why?
|
| Mammals | 1 | 2022 | 222 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2021 | 52 | 0.160 |
Why?
|
| Computational Biology | 2 | 2013 | 367 | 0.160 |
Why?
|
| HeLa Cells | 1 | 2021 | 541 | 0.150 |
Why?
|
| Meiosis | 2 | 2011 | 80 | 0.150 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2019 | 5 | 0.150 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 361 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 699 | 0.150 |
Why?
|
| Genomic Instability | 2 | 2017 | 59 | 0.150 |
Why?
|
| Microscopy, Video | 1 | 2019 | 38 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 856 | 0.150 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 1979 | 0.140 |
Why?
|
| Fungal Proteins | 2 | 2017 | 152 | 0.140 |
Why?
|
| Chromosomes, Fungal | 3 | 2016 | 34 | 0.140 |
Why?
|
| Phylogeny | 3 | 2023 | 388 | 0.140 |
Why?
|
| Tetrahymena | 1 | 2017 | 6 | 0.140 |
Why?
|
| Spliceosomes | 1 | 2018 | 42 | 0.130 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2017 | 4 | 0.130 |
Why?
|
| Mycology | 2 | 2009 | 6 | 0.130 |
Why?
|
| Replication Protein A | 1 | 2017 | 14 | 0.130 |
Why?
|
| Bleomycin | 1 | 2017 | 35 | 0.130 |
Why?
|
| Centromere | 2 | 2023 | 45 | 0.130 |
Why?
|
| Cell Biology | 1 | 2017 | 22 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 794 | 0.130 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 256 | 0.130 |
Why?
|
| Erythroid Cells | 1 | 2017 | 13 | 0.130 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 70 | 0.130 |
Why?
|
| Aneuploidy | 1 | 2017 | 42 | 0.130 |
Why?
|
| Interphase | 1 | 2017 | 68 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1565 | 0.120 |
Why?
|
| Transcriptome | 2 | 2018 | 399 | 0.120 |
Why?
|
| Mutation | 3 | 2010 | 2661 | 0.120 |
Why?
|
| Telomere | 2 | 2009 | 58 | 0.120 |
Why?
|
| RNA, Fungal | 2 | 2018 | 44 | 0.120 |
Why?
|
| Cell Wall | 1 | 2016 | 118 | 0.110 |
Why?
|
| Sex Determination Analysis | 1 | 1995 | 5 | 0.110 |
Why?
|
| Nucleotide Motifs | 2 | 2012 | 52 | 0.110 |
Why?
|
| Genes, Helminth | 1 | 1995 | 58 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 180 | 0.110 |
Why?
|
| Helminth Proteins | 1 | 1995 | 51 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 146 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2008 | 630 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 312 | 0.100 |
Why?
|
| Binding Sites | 2 | 2012 | 921 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 59 | 0.090 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 21 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2008 | 449 | 0.090 |
Why?
|
| Base Sequence | 4 | 2011 | 1332 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2010 | 391 | 0.090 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2011 | 5 | 0.090 |
Why?
|
| Protein Kinases | 2 | 2010 | 153 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 296 | 0.080 |
Why?
|
| Heterochromatin | 1 | 2012 | 98 | 0.080 |
Why?
|
| RNA, Antisense | 1 | 2011 | 50 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 38 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 663 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 67 | 0.080 |
Why?
|
| Algorithms | 2 | 2018 | 1050 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 105 | 0.080 |
Why?
|
| Genes, Fungal | 1 | 2010 | 56 | 0.080 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1995 | 447 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2011 | 160 | 0.080 |
Why?
|
| Probability | 1 | 2010 | 170 | 0.080 |
Why?
|
| Cell Separation | 1 | 2009 | 147 | 0.070 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 43 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 385 | 0.070 |
Why?
|
| Spores, Fungal | 1 | 2009 | 22 | 0.070 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 27 | 0.070 |
Why?
|
| Microbial Viability | 1 | 2009 | 56 | 0.070 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2008 | 23 | 0.070 |
Why?
|
| Hydroxyurea | 1 | 2008 | 19 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 2 | 2010 | 45 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 316 | 0.070 |
Why?
|
| Glucose | 1 | 2011 | 476 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2010 | 962 | 0.070 |
Why?
|
| Genomics | 1 | 2011 | 384 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 1995 | 706 | 0.070 |
Why?
|
| Plasmids | 1 | 2008 | 294 | 0.070 |
Why?
|
| Cell Survival | 1 | 2009 | 587 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 426 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1589 | 0.060 |
Why?
|
| Time Factors | 3 | 2010 | 3762 | 0.060 |
Why?
|
| Transformation, Genetic | 1 | 2006 | 31 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 116 | 0.060 |
Why?
|
| Phenotype | 1 | 2009 | 1233 | 0.050 |
Why?
|
| Genotype | 1 | 2006 | 673 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 981 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2003 | 173 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 162 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 364 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2016 | 312 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2004 | 433 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 790 | 0.040 |
Why?
|
| Introns | 1 | 2018 | 114 | 0.030 |
Why?
|
| Karyotype | 1 | 2017 | 18 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2018 | 116 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 72 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 170 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 301 | 0.030 |
Why?
|
| Disorders of Sex Development | 1 | 1995 | 12 | 0.030 |
Why?
|
| Gastrula | 1 | 1995 | 13 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 23 | 0.030 |
Why?
|
| RNA, Helminth | 1 | 1995 | 47 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 251 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 1995 | 184 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1995 | 138 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 500 | 0.020 |
Why?
|
| Ascomycota | 1 | 2011 | 10 | 0.020 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 300 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 261 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 327 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1995 | 1574 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 1368 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 129 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 301 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 11119 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 372 | 0.010 |
Why?
|
| Female | 1 | 2017 | 34018 | 0.010 |
Why?
|
| Male | 1 | 1995 | 31047 | 0.010 |
Why?
|